These ETFs profit from steady demand

Traditionally, the price of most stocks, and the ETFs that hold them, drop during bear markets like the one we saw in 2022. However, certain segments generally perform better than the overall market during downturns—and bounce back faster, including during the 2000-2002 and 2008-2009 bear… Read More

Former parent is the better pick

Merck—like other big pharmaceutical makers Pfizer and Johnson & Johnson—recently spun off some of its legacy businesses. Merck’s split came in June 2021 with the creation of Organon & Co. Investors received one share in the new firm for every 10 Merck shares they held.
Since… Read More